Hospital News and Research

RSS

Mayo Clinic experts available to discuss latest colorectal cancer research and treatment

March is National Colorectal Cancer Awareness Month. Colon cancer is one of the most common and deadly cancers, and also one of the most preventable. Mayo Clinic experts are available to discuss the latest in colorectal cancer research, detection and treatment.

6 Mar 2012

Cross Country Healthcare fourth quarter revenue increases 10% to $124.7M

Cross Country Healthcare, Inc. today reported revenue of $124.7 million in the fourth quarter ended December 31, 2011, a 10% increase from revenue of $113.7 million in the prior year quarter and a 5% decrease sequentially from the third quarter of 2011.

6 Mar 2012

Stereotaxis fourth quarter net loss increases to $5.5M

Stereotaxis, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2011.

6 Mar 2012

New, freely available Web-based program helps predict effect of mutations on mRNA splicing

In a brief paper in the journal Bioinformatics, Brown University researchers describe a new, freely available Web-based program called Spliceman for predicting whether genetic mutations are likely to disrupt the splicing of messenger RNA, potentially leading to disease.

6 Mar 2012

PGen study to examine impact of consumer genomics

As genetic risk information plays an increasingly important role in the diagnosis and treatment of many diseases, private companies have made personal genomic testing for these risk factors widely available to the public. However, very little data has been gathered to understand the motivations and expectations of consumers of personal genomic services, the psychological and behavioral impact of these services, and the associated ethical, legal and social issues-until now.

5 Mar 2012

National Council for Research on Women honors CINJ breast oncologist

The chief medical officer at The Cancer Institute of New Jersey (CINJ) has been named as one of this year's 30 'Outstanding Women' by the National Council for Research on Women. Deborah L. Toppmeyer, MD, a medical oncologist at CINJ who heads a very active breast cancer clinic and conducts clinical research, was selected for her commitment to issues critical to advancing women and women's health.

5 Mar 2012

Scientists successfully cultivate stem cells on human corneas

A new cornea may be the only way to prevent a patient going blind - but there is a shortage of donated corneas and the queue for transplantation is long. Scientists at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have for the first time successfully cultivated stem cells on human corneas, which may in the long term remove the need for donators.

5 Mar 2012

AMAG fourth quarter total revenues decrease to $14.9 million

AMAG Pharmaceuticals, Inc. a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2011. As of December 31, 2011, the company's cash, cash equivalents and investments totaled approximately $230 million.

5 Mar 2012

$Vitamin D in pre-teen girls protects from stress fractures and bone injuries: Study$

Vitamin D in pre-teen girls protects from stress fractures and bone injuries: Study

A new study shows that girls and young women who got lots of vitamin D through their diet and supplements were half as likely to suffer a stress fracture as those who didn't.

5 Mar 2012

Antidepressants in pregnancy: weighing benefits and risks

There has been a debate on the use of antidepressant medication in pregnant women. Depression during pregnancy is, of course, difficult for the woman. In addition, depression that continues in the postpartum period may interfere with caretaking and bonding with the newborn.

5 Mar 2012

The Contraception Mandate is the end of individual liberty

In March 2010, the Democrat-controlled Congress forced the passage of the Patient Protection and Affordable Care Act (now known as ObamaCare) over the strong objections of the majority of Americans, most of whom were either already receiving taxpayer-funded health insurance or were satisfied with their private coverage.

5 Mar 2012

Asthma first aid charts launched

The National Asthma Council Australia has updated its popular First Aid for Asthma chart and launched a new paediatric Kids’ First Aid for Asthma chart, with advice reflecting the latest evidence and medications.

5 Mar 2012

Medtronic launches MRI passive leads approved for full body MRI scans

Medtronic, Inc. today announced the receipt of CE Mark (Conformité Européenne) and launch of the CapSure Sense MRI SureScan® pacing leads, which are approved for use during Magnetic Resonance Imaging (MRI). Medtronic introduced the first MR-Conditional pacemaker system in the world in 2008 and in the U.S. in 2011.

From Medtronic 5 Mar 2012

Innovative telemedicine program connects neonatal specialists to treat tiniest, difficult cases

An innovative telemedicine program connecting neonatal specialists from UC San Diego Medical Center and Tri-City Medical Center's Neonatal Intensive Care Unit (NICU) will allow experts to collaborate, diagnose and treat some of San Diego County's tiniest, most difficult cases.

5 Mar 2012

Thrombotech receives FDA IND approval for THR-18 Phase IIa clinical trial in stroke victims

Hadasit Bio-Holdings a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced Thrombotech Ltd., a portfolio company which Hadasit holds a 24% stake in, received an IND approval from the Food and Drug Administration enabling the initiation of a Phase IIa clinical trial in the U.S.

5 Mar 2012

First Edition: March 5, 2012

Today's headlines include reports setting the scene for the upcoming "Super Tuesday" primary elections and how GOP presidential candidates are pointing to health policy issues as part of the debate.

5 Mar 2012

Exelixis initiates cabozantinib and abiraterone phase 1 combination trial in CRPC

Exelixis Inc. today announced the initiation of a phase 1 dose-finding trial of cabozantinib in combination with abiraterone in men with metastatic castration-resistant prostate cancer (CRPC) who have disease progression following treatment with up to two prior chemotherapy regimens.

5 Mar 2012

diaDexus introduces new PLAC Activity test in Europe

diaDexus, Inc., a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced the commercial launch of its CE-marked PLAC Test for Lp-PLA(2) Activity in Europe.

5 Mar 2012

Young children with SDB more likely to develop neurobehavioral problems

A study of more than 11,000 children followed for over six years has found that young children with sleep-disordered breathing are prone to developing behavioral difficulties such as hyperactivity and aggressiveness, as well as emotional symptoms and difficulty with peer relationships, according to researchers at Albert Einstein College of Medicine of Yeshiva University.

5 Mar 2012

CSOS to comply with international emergency medical service protocols

CSOS, China's first emergency assistance specialist with a global servicing capability and hospital network, announced today that it has been in full compliance with international emergency medical service (EMS) protocols as an initiative to promote best emergency care practices and medical excellence for government agencies, insurance companies, institutional clients and to the general public in China.

5 Mar 2012